LR-19018

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameLR-19018
Drug Alias NameLR-19018LG-203003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase inhibitors
TargetsDiacylglycerol O-acyltransferase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLG Chem Life Sciences Innovation Center Inc
China Registration ClassN/A

Develop Information

Active CompaniesLG Chem Life Sciences Innovation Center Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A